Scarica l'app Stockscreener
0.6756
5.55%
0.0355
Dopo l'orario di chiusura:
.68
0.0044
+0.65%
Precedente Chiudi:
$0.6401
Aprire:
$0.64
Volume 24 ore:
482.95K
Relative Volume:
1.01
Capitalizzazione di mercato:
$26.02M
Reddito:
$40.93M
Utile/perdita netta:
$-15.57M
Rapporto P/E:
-1.8147
EPS:
-0.3723
Flusso di cassa netto:
$-17.84M
1 W Prestazione:
-3.07%
1M Prestazione:
-12.83%
6M Prestazione:
-24.26%
1 anno Prestazione:
-85.95%
Intervallo 1D:
$0.605
$0.6918
Intervallo di 1 settimana:
$0.605
$0.73
Portata 52W:
$0.605
$5.0368
Myomo Inc Stock (MYO) Company Profile
Nome
Myomo Inc
Settore
Industria
Telefono
617-996-9058
Indirizzo
One Broadway, 14th Floor, Cambridge, MA
Compare MYO vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MYO
Myomo Inc
|
0.6756 | 24.65M | 40.93M | -15.57M | -17.84M | -0.3723 |
ABT
Abbott Laboratories
|
102.67 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.59 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.65 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.75 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Myomo Inc Stock (MYO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-31 | Iniziato | Craig Hallum | Buy |
| 2024-05-20 | Iniziato | Lake Street | Buy |
| 2023-12-15 | Iniziato | H.C. Wainwright | Buy |
| 2020-11-11 | Aggiornamento | ROTH Capital | Neutral → Buy |
| 2020-05-27 | Iniziato | Dougherty & Company | Buy |
| 2017-10-02 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Myomo Inc Borsa (MYO) Ultime notizie
If You Invested $1,000 in Myomo (MYO) - Stock Titan
EV Market: What is Myomo Incs 5 year growth outlookQuarterly Profit Review & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Institution Moves: Will Myomo Inc benefit from geopolitical trendsWall Street Watch & Community Shared Stock Ideas - baoquankhu1.vn
Myomo (MYO) price target decreased by 13.60% to 4.41 - MSN
MYO Stock Price, Quote & Chart | MYOMO INC (NYSEARCA:MYO) - ChartMill
EPS Watch: Is Myomo Inc a potential multi baggerMarket Trend Review & Technical Pattern Recognition Alerts - baoquankhu1.vn
Getz Heather C, director at Myomo, buys $13,972 in stock By Investing.com - Investing.com Australia
Getz Heather C, director at Myomo, buys $13,972 in stock - Investing.com
Myomo (MYO) director Heather Getz purchases 20,000 common shares - Stock Titan
Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates - MSN
2026 Week #11: Where “Exoskeleton” Came From, Myomo Expands Coverage, Exo Games Return - Exoskeleton Report
Kirk Thomas F buys Myomo (MYO) shares worth $51,112 By Investing.com - Investing.com South Africa
Kirk Thomas F buys Myomo (MYO) shares worth $51,112 - Investing.com
Myomo (MYO) director adds 72,000 MYO shares in open-market purchase - Stock Titan
Elevance Expands Myomo Coverage And Broadens Technology Enabled Care Story - Sahm
MYOMO (MYO) director boosts stake with 70,000-share open-market buy - Stock Titan
Elevance Expands Myomo Coverage To Support Tech Enabled Care Narrative - Yahoo Finance
Myomo price target lowered to $3 from $4 at Alliance Global - TipRanks
Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH), Myomo (MYO) and OS Therapies Incorporated (OSTX) - The Globe and Mail
Myomo Inc. Flags High Risk in Forward-Looking Statements, Urges Caution on Reimbursement, Financing and Growth Plans - The Globe and Mail
Myomo Inc (MYO) Q4 2025 Earnings Call Highlights: Record Revenue - GuruFocus
Craig-Hallum Maintains Buy on Myomo, Inc. (MYO) March 2026 - Meyka
Craig-Hallum cuts Myomo stock price target to $1.10 on guidance miss - Investing.com Australia
Myomo enters network agreement with Elevance Health plans - Investing.com Australia
Analysts Offer Insights on Healthcare Companies: Dianthus Therapeutics (DNTH), Myomo (MYO) and Hims & Hers Health (HIMS) - The Globe and Mail
Myomo, Inc. 2026 Annual Report: Market Leadership, Competitive Risks, and Myoelectric Orthotics Business Overview - Minichart
Myomo’s operating loss hits USD 2.8M in Q4 2025 - Medical Buyer
MYO Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Myomo Q4 2025 Earnings Call Transcript - MarketBeat
Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates - Bitget
Myomo Reports Fourth Quarter and Full Year 2025 Financial and Operating Results - 01net
Myomo earnings missed, revenue topped estimates By Investing.com - Investing.com Canada
Myomo reports Q4 EPS (9c), consensus (9c) - TipRanks
MYO Posts Strong Q4 Revenue Surpassing Expectations - GuruFocus
Myomo (MYO) Projects Lower Q1 Revenue Amid Market Expectations - GuruFocus
Myomo sees FY26 revenue $43M-$46M, consensus $46.97M - TipRanks
Myomo, Elevance agree to contract for multi-state network participation - TipRanks
Elevance Health (ELV) Partners with Myomo to Expand Access to My - GuruFocus
Myomo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Myomo Q4 revenue falls on lower average selling price - TradingView
Myomo (NYSE: MYO) grows 2025 revenue 26% but posts larger annual loss - Stock Titan
Earnings Breakdown: Myomo Q4 - Benzinga
BRIEF-Myomo Q4 EPS USD -0.09 - TradingView
Press Release: Myomo Reports Fourth Quarter and Full Year 2025 Financial and Operating Results - 富途牛牛
Myomo and Elevance Health Agree to Contract for Multi-State Network Participation - Business Wire
Gains Recap: Can Myomo Inc sustain earnings growth2025 Growth vs Value & Fast Entry Momentum Alerts - baoquankhu1.vn
Myomo to Announce Q4 Earnings on March 9 - Intellectia AI
Myomo Inc Azioni (MYO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Myomo Inc Azioni (MYO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| KIRK THOMAS F | Director |
Mar 13 '26 |
Buy |
0.71 |
72,000 |
51,113 |
553,857 |
| Getz Heather C | Director |
Mar 12 '26 |
Buy |
0.73 |
70,000 |
50,960 |
111,754 |
| KIRK THOMAS F | Director |
Nov 20 '25 |
Buy |
0.72 |
4,902 |
3,529 |
479,322 |
| KIRK THOMAS F | Director |
Nov 21 '25 |
Buy |
0.72 |
2,535 |
1,825 |
481,857 |
| Crowley Thomas Aloysius Jr. | Director |
Nov 18 '25 |
Buy |
0.73 |
4,000 |
2,938 |
75,748 |
| Crowley Thomas Aloysius Jr. | Director |
Nov 19 '25 |
Buy |
0.77 |
385 |
295 |
479 |
| KIRK THOMAS F | Director |
Aug 25 '25 |
Buy |
1.15 |
50,000 |
57,500 |
474,420 |
| KIRK THOMAS F | Director |
Aug 18 '25 |
Buy |
1.10 |
50,000 |
55,000 |
424,420 |
| GUDONIS PAUL R | Chief Executive Officer |
Aug 15 '25 |
Buy |
0.95 |
50,000 |
47,295 |
1,259,013 |
2.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):